Wnt2b对肝细胞癌生物学功能的影响及相关机制探究
[Abstract]:Objective liver cancer is one of the most fatal malignant tumors and is also a major disease which threatens human health. The incidence of liver cancer is always high. In China, the mortality rate of liver cancer ranks second and the incidence is fourth. The diagnosis of liver cancer is mainly the detection of tumor markers and the imaging examination. The methods for the treatment of liver cancer are very important. Many, such as surgical excision, etc., however, although effective treatment, liver cancer still has the possibility of recurrence and metastasis. Therefore, it is necessary to further clarify the molecular mechanism of the occurrence of liver cancer, find different molecular and abnormal signal pathways in the occurrence of liver cancer, find new ways to effectively treat liver cancer, and provide new directions for clinical treatment. In recent years, some scholars have found that there are abnormal signaling pathways in the development of liver cancer. It is worthy of our attention that the activation of the classical Wnt signaling pathway.Wnt signaling pathway is a highly conserved signaling pathway during the development and development of liver cancer, which is in the development of the embryo, tissue repair and regeneration in the organism. Regulation of cell growth, apoptosis, self renewal and expression of survival genes plays an important role. According to the different signaling pathways that are activated, the Wnt signaling pathway is a classic signaling pathway if it depends on the role of beta -catenin molecules; if not dependent, it is a nonclassical pathway. The research on Wnt and the liver is mainly focused on Wnt signaling pathway plays a role in the process of liver fibrosis. Studies have shown that when the classic Wnt signaling pathway is activated, hepatic stellate cells can be activated to lead to liver fibrosis. However, there are few studies on the Wnt signaling pathway and the liver cancer, and the research on the Wnt family is mainly focused on the early work of Wnt3a and Wnt5a.. We found that, compared with normal liver tissue, the Wnt2b molecule in the liver is highly expressed and has a certain correlation with the severity of the disease. On the premise of TLR4 promoting HCC and TLR2 inhibition of HCC, we found that TLR4 activator stimulates human hepatoma cell line (HepG2, H7702) and rat hepatoma cell line (Hepa1-6) Wnt2b expression up-regulated, TL These results suggest that Wnt2b may play a key role in the development of liver cancer. According to the experimental phenomena mentioned above, the effects of Wnt2b on the tumor biological characteristics of hepatoma cells are discussed in this study in vitro, and the mechanism of Wnt2b is discussed. In vivo experiments have proved that Wnt2b promotes the growth of tumor in mice and inhibits the number and proportion of NK cells in tumor tissues. In addition, this study has preliminarily explored the application of inhibiting the expression of Wnt2b to assist in the treatment of liver cancer, and provides new targets and experimental basis for the treatment of liver cancer. Method 1. study several common human and rat hepatoma cells The effects of TLR2 agonist Pam3CSK4 and TLR4 agonist LPS on the proliferation of hepatoma cells were measured by MTT method, and.2. using immunofluorescence, immunohistochemistry and Western blot method to detect the effect of TLR4 on the beta -catenin in liver cancer cell lines and liver cancer tissues,.3. with different TLR deletion mice was used as a model. Semi quantitative RT-PCR method was used to detect the basic expression level of Wnts mRNA. Semi quantitative RT-PCR method was used to detect the effect of TLR2 and TLR4 on the mRNA level of all Wnts in human hepatoma cell HepG2.4. using semi quantitative RT-PCR method and Western limitation. The effect of Wnt2b on the proliferation of hepatoma cells was detected by TT. Cell colony formation and Real-time PCR were used to investigate the effect of Wnt2b on the stem of liver cancer cell lines. PI single staining and Annexin V/PI double staining were used to detect the effect of Wnt2b molecules on the cell cycle and apoptosis of hepatoma cells respectively..6. used Western blot. Whether the function of the cell was activated by the activation of Wnt signaling pathway in.7. animal experiment, the tumor was charged by subcutaneous tumor tissue, the transfection of plasmids and intratumoral injection were used to observe the effect of Wnt2b on the tumor, and the changes of lymphocyte subsets in the tumor tissues and liver were detected by flow cytometry. The results of the study were that 1.TLR2 inhibited the proliferation of the liver cancer cell lines, and TLR4 promoted the proliferation of the liver cancer cell lines. The proliferation of hepatoma cell line.TLR2 inhibits the dry nature of hepatoma cells, and TLR4 promotes the expression and nucleation of beta -catenin in liver cancer cell lines by promoting the dry.2.TLR4 of hepatoma cells. The expression of beta -catenin in the liver tissues of WT mice is up to up, and the nucleated beta -catenin increases in the liver tissues of the mice lacking TLR in.3. and TLR. Wnts expression of different.TLR2 agonists stimulated the human hepatoma cell line HepG2, Wnt2 molecules, and Wnt2b molecules down regulated. The expression of Wnt5a molecules was down regulated by TLR4 agonist LPS, and Wnt2b molecule expression up.4.TLR2 inhibited the Wnt2b expression in hepatoma cell lines. TLR4 promoted the expression of the hepatocellular carcinoma cell line to promote the liver cancer cell line The proliferation of.Wnt2b stimulates the dry.Wnt2b of hepatoma cells to inhibit the apoptosis of hepatoma cell lines and promote the expression of anti apoptotic gene Bcl-2 and Mcl-1, but does not affect the promoting effect of.6.Wnt2b on liver cancer by activating Wnt/ beta -catenin signaling pathway. After silent beta -catenin, Wnt2b can not play a role in promoting liver cancer. .7.Wnt2b promotes the growth of tumor and inhibits the number of NK cells in tumor tissue. Conclusion and significance 1, this paper first discovered the effect of TLR2 and TLR4 molecules on the expression of Wnt2b in the process of liver cancer, and found that TLR4 molecules promote the activation of beta -catenin, and the first discovery of Wnt2b to the liver for TLR signaling pathway and Wnt signaling pathway is the first discovery of Wnt2b on the liver. The promoting effect of cell cancer cells, and elucidates its intrinsic mechanism, is found to mediate the proliferation of hepatoma cells by activating the Wnt signaling pathway. In vivo, Wnt2b promotes tumor growth by inhibiting NK cells and provides a new direction for the treatment of cancer in the future.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R735.7
【相似文献】
相关期刊论文 前10条
1 方肇勤,管冬元;二十年来国内建立的肝癌细胞系及其特性[J];肿瘤防治研究;1997年05期
2 王勇姿,俞超芹,凌昌全,卫立辛;肝癌细胞系的研究概况[J];上海医学;2000年02期
3 王蓬,陈孝平,PBSLai,CK Leow,Joseph W Y Lau;二十碳五烯酸对三种肝癌细胞系作用的实验研究[J];中华普通外科杂志;2001年01期
4 彭林,王卫东,孙建,简志祥,杜嘉林,区金锐;稳定表达促血管生成素基因肝癌细胞系的建立及产物的检测[J];广东医学;2003年07期
5 赵荡;陈宏武;许磊;刘飞勇;;不同时期肝癌免疫杀伤肿瘤细胞效应探讨[J];中山大学学报(医学科学版);2006年S1期
6 郭晓林;姜雅秋;金清龙;;多药耐药相关蛋白-3表达与肝癌耐药的相关性[J];中国老年学杂志;2010年11期
7 ;离体培养的人体肝癌细胞系的建立[J];医学研究通讯;1978年10期
8 陆荣华;陈尊器;陈瑞铭;;人体肝癌细胞系体外恶性浸润行为的研究[J];细胞生物学杂志;1982年02期
9 张志培,施新猷,李六金,刘雪松,江逊,彭磊,赵佐庆;小鼠免疫力对接种人类肝癌细胞系9724生长的影响[J];第四军医大学学报;2001年07期
10 张志仁,徐顺清,周宜开,任恕,刘志伟,吕斌,徐永俊;一株受二VA英类化学物质诱导表达的萤光素酶肝癌细胞系[J];中国生物化学与分子生物学报;2001年06期
相关会议论文 前10条
1 符兆英;刘凯歌;徐光华;;肝癌细胞系中乙型肝炎病毒x蛋白与缺氧诱导因子-1α表达的研究[A];中国细胞生物学学会2005年学术大会、青年学术研讨会论文摘要集[C];2005年
2 张朵;朱海英;谢东莆;胡以平;;肝癌细胞中存在SP细胞[A];中国细胞生物学学会2005年学术大会、青年学术研讨会论文摘要集[C];2005年
3 汪谦;曹良启;陈锡林;甄茂川;黄晓卉;傅新晖;;过氧化物酶增殖物激活受体活化抑制肝癌细胞迁移的研究[A];广东省肝脏病学会2007年年会论文集[C];2007年
4 邓欣;蒋小玲;李辉;吴其恺;聂广;刘钦;;表达耐拉米夫定乙型肝炎病毒肝癌细胞系的建立[A];第一次全国中西医结合传染病学术会议论文汇编[C];2006年
5 吴尘轩;杜智;朱争艳;高英堂;王毅军;只丹琮;孙泉;;肝癌免疫治疗微环境和树突状细胞体外诱导的实验研究[A];天津市生物医学工程学会2007年学术年会论文摘要集[C];2007年
6 赵主江;单云峰;樊红;程欲超;成建;权艳梅;张建琼;谢维;;DNMT3A siRNA稳定表达载体的构建及其沉默效率的鉴定[A];江苏省遗传学会第七届代表大会暨学术研讨会论文摘要汇编[C];2006年
7 田德安;;RhoA短发夹状双链RNA对肝癌细胞生物学行为的调控研究[A];中华医学会第七次全国消化病学术会议论文汇编(下册)[C];2007年
8 高倩;;肝癌HepG2细胞系分泌的免疫抑制物质的研究[A];第六届全国免疫学学术大会论文集[C];2008年
9 代智;刘银坤;冯巨涛;宋海燕;申华丽;张丽君;崔杰峰;;高低转移潜能肝癌细胞系差异糖蛋白质组学研究[A];中国蛋白质组学第二届学术大会论文摘要论文集[C];2004年
10 张盛周;俞明月;谢晶;戴谷;李朝军;;Met与Fas基因在肝癌组织和肝癌细胞系中的表达[A];中国细胞生物学学会第八届会员代表大会暨学术大会论文摘要集[C];2003年
相关重要报纸文章 前1条
1 记者 胡德荣;肝癌患者自噬性缺陷表型与预后不良紧密相关[N];健康报;2008年
相关博士学位论文 前10条
1 王骥;凝集素富集糖肽联合酶促~(18)O_3标记的定量N-糖蛋白组学方法在肝癌术后转移复发研究中的应用[D];复旦大学;2012年
2 刘坤;Bcl-2/Twist1蛋白互作在缺氧促进肝癌血管生成拟态形成中的作用[D];天津医科大学;2015年
3 林镇海;NR1D1通过DUOX2/MCP-1途径募集巨噬细胞促进肝癌侵袭转移的机制及临床研究[D];复旦大学;2014年
4 丁坤;骨桥蛋白促进肝癌细胞顺铂耐药的实验研究[D];山东大学;2016年
5 马春亮;KLF17在肝癌中的作用及对肝癌预后的影响[D];北京协和医学院;2016年
6 幸思忠;URG4/URGCP激活NF-κB通路调控肝细胞癌血管增生的实验研究[D];南方医科大学;2016年
7 范娅涵;Hedgehog信号通路调控Twist1表达促进肝癌细胞侵袭转移分子机制研究[D];第三军医大学;2016年
8 张素洁;长非编码RNA LncTSG1抑制肝癌转移的功能及机制研究[D];中国人民解放军医学院;2016年
9 梁东;Fbxw7促进Slug降解抑制TGF-β诱导的肝癌转移[D];福建医科大学;2015年
10 陶其飞;肝癌患者来源的移植瘤模型构建、特征描述及基于此模型的索拉菲尼耐药标志物研究[D];第二军医大学;2016年
相关硕士学位论文 前10条
1 田芸芸;人脐带MSCs上清对肝癌细胞系HepG2影响的比较转录组学研究[D];内蒙古大学;2015年
2 徐辰;NKCC1促进肝癌细胞转移的分子机制及其抑制剂用于抗肿瘤药物的探索[D];安徽医科大学;2015年
3 杨霞;循环肝癌细胞CD147表型鉴定在指导利卡汀个体化治疗中的应用潜能探索[D];苏州大学;2015年
4 石志勇;FOXF2在肝癌中的表达及其对预后价值的研究[D];苏州大学;2015年
5 陈杨;缺氧诱导肝癌细胞EMT及相关机制研究[D];中国人民解放军医学院;2015年
6 唐俊;miR-612对肝癌细胞干性的调节作用及其机制[D];复旦大学;2014年
7 李韵;miR-27b-5p促进肝癌细胞向肝癌干样细胞转化及其机制研究[D];四川医科大学;2015年
8 李霄;BMP4对肝癌VM形成影响的研究[D];天津医科大学;2015年
9 曹漪伊;HBV通过上调miR-331-3p的表达从而促进肝癌细胞的增殖[D];重庆医科大学;2015年
10 黄亚运;以热休克蛋白为靶点的抗HBV药物研究[D];湖北工业大学;2016年
,本文编号:2145159
本文链接:https://www.wllwen.com/yixuelunwen/zlx/2145159.html